Picture of Emergent BioSolutions logo

EBS — Emergent BioSolutions News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Emergent Biosolutions supports new clinical trial evaluating the safety and efficacy of Brincidofovir in treating Mpox virus across Africa

Nov 6 (Reuters) - Emergent BioSolutions Inc  EBS.N :
    * EMERGENT BIOSOLUTIONS SUPPORTS NEW CLINICAL TRIAL
EVALUATING THE
SAFETY AND EFFICACY OF BRINCIDOFOVIR IN TREATING MPOX VIRUS
ACROSS AFRICA
    * EMERGENT BIOSOLUTIONS INC - STUDY TO EVALUATE SAFETY AND
EFFICACY OF TEMBEXA FOR MPOX
    * EMERGENT BIOSOLUTIONS INC - MOSA TRIAL TO BEGIN IN DRC AND
NEIGHBORING COUNTRIES

Source text:  ID:nGNX83kM6m 
Further company coverage:  EBS.N 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Emergent BioSolutions

See all news